Evidence map›Paper›PMID 41659091›Full record

ArticleReviews in cardiovascular medicine2026

Reference Values for Myocardial Strain by Cardiac Magnetic Resonance Feature Tracking: Insights From Healthy Volunteers and Heart Failure Patients Using Caas MR.

Karl Jakob Weiss, Shing Ching, Patrick Doeblin, Irene Carrión-Sánchez, Karina Carrizosa, Radu Tanacli, Stefanie Werhahn, Jana Veit, Rebecca Elisabeth Beyer, Nicole Mittmann and 6 more

Abstract read
In one paragraph

Article in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Karl Jakob WeissDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Shing ChingDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Patrick DoeblinDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Irene Carrión-SánchezDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.ORCID https://orcid.org/0000-0003-2998-7147
Karina CarrizosaDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Radu TanacliDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Stefanie WerhahnDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Jana VeitDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Rebecca Elisabeth BeyerDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Nicole MittmannDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Christian StehningPhilips Clinical Science, Philips Healthcare, 22335 Hamburg, Germany.
Gaston VogelPie Medical Imaging BV, Product Management, 6227 AK Maastricht, The Netherlands.
Hans-Dirk DüngenDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Moritz BlumCharité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
Djawid HashemiDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
Sebastian KelleDepartment of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Magnetic resonance imaging (MRI) allows for the assessment of myocardial strain and identification of heart failure (HF) patients with reduced (HFrEF), mildly reduced (HFmrEF), or preserved (HFpEF) left ventricular ejection fraction (LVEF). The cardiovascular angiographic analysis system magnetic resonance (Caas MR) strain (Pie Medical Imaging) has recently been implemented in the IntelliSpace Portal Suite (Philips Healthcare) to assess the global longitudinal strain (GLS), global circumferential strain (GCS), and global radial strain (GRS). However, standard values for this software across different HF entities, as well as normal values, have yet to be established. Thus, this study aimed to establish reference values for the GLS, GCS, and GRS using the Caas MR strain in healthy individuals and HF patients, to assess the ability of these parameters to differentiate between HF subtypes, and to compare CAAS-derived strain values with those obtained using CVI42 software. Methods: Using a 1.5 T Philips Achieva scanner, we analyzed 19 healthy volunteers and 56 HF patients (HFpEF, n = 19; HFmrEF, n = 20; and HFrEF, n = 17) using the feature tracking post-processing software Caas MR Strain. GLS, GCS, and GRS were quantified using 4-chamber-view, 2-chamber-view, and short-axis (SAX) cine images. All volunteers and patients were evaluated by CVI42 to analyze inter-vendor reliability with a validated software. Results: Mean GLS, GCS, and GRS by Caas MR Strain were significantly different for healthy volunteers compared to HF patients (GLS -15.8 ± 1.9% vs. -11.7 ± 3.0%, Conclusion: Magnetic resonance imaging assessment of left ventricular myocardial strain using Caas MR Strain software reliably identifies HF patients. Discrimination between the different HF entities is potentially feasible by GLS, GCS, and GRS. Intervendor agreement was most robust for GLS and GCS, but less robust for GRS. For practical clinical use, we propose cut-off values for GLS above -15%, GCS above -15%, and GRS below 23% to define pathological findings.

Indexed as

cardiac magnetic resonancedeformation imagingfeature trackinghealthyheart failurepatientsstrain

Identifiers

PMID41659091
PMCPMC12873689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.